Continental Advisors’s Science 37 Holdings, Inc. Common Stock SNCE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-22,284
Closed -$119K 49
2023
Q4
$119K Hold
22,284
0.05% 48
2023
Q3
$178K Buy
22,284
+5,882
+36% +$35K 0.1% 50
2023
Q2
$69.7K Hold
16,402
0.03% 54
2023
Q1
$92.4K Hold
16,402
0.05% 50
2022
Q4
$136K Buy
+16,402
New +$321K 0.07% 60

Continental Advisors's SNCE Position: Q1 2024 in Review

Continental Advisors sold out of Science 37 Holdings, Inc. Common Stock (SNCE) in Q1 2024, closing a stake of 22,284 shares — an estimated $119K sold.

Continental Advisors first reported a position in SNCE in Q4 2022 and held it in 5 quarters. The position peaked at $178K in Q3 2023. 0 funds tracked by Wall St. Rank hold SNCE as of Q1 2024.

  • Continental Advisors reported no remaining Science 37 Holdings, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Continental Advisors sold 22,284 Science 37 Holdings, Inc. Common Stock shares in Q1 2024, an estimated $119K.
  • Continental Advisors first reported a position in Science 37 Holdings, Inc. Common Stock in Q4 2022 and held it in 5 quarters.
  • Continental Advisors's Science 37 Holdings, Inc. Common Stock position peaked at $178K in Q3 2023.
  • 0 funds tracked by Wall St. Rank held Science 37 Holdings, Inc. Common Stock as of Q1 2024.

Based on Continental Advisors's 13F filing for Q1 2024, filed 15 May 2024.